| Symbol | Company | Weighting |
|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP USD | 5.52% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 4.33% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 4.17% |
| RNA | AVIDITY BIOSCIENCES INC | 3.80% |
| IONS | IONIS PHARMACEUTICALS INC | 3.46% |
| NTRA | NATERA INC | 3.40% |
| ARGX | ARGENX SE ADR | 3.35% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 3.26% |
| EXAS | EXACT SCIENCES CORP | 3.14% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.93% |
| TARS | TARSUS PHARMACEUTICALS | 2.63% |
| MCK | MCKESSON CORP | 2.41% |
| HCA | HCA HOLDINGS INC | 2.29% |
| NUVL | NUVALENT INC | 2.24% |
| ALKS | ALKERMES INC | 2.18% |
| ISRG | INTUITIVE SURGICAL INC | 2.01% |
| IDXX | IDEXX LABS CORP | 1.94% |
| BSX | BOSTON SCIENTIFIC | 1.93% |
| AZN | ASTRAZENECA PLC-ADR | 1.85% |
| SYK | STRYKER CORP | 1.73% |
| LLY | ELI LILLY CORP | 1.67% |
| DNLI | DENALI THERAPEUTICS INC. | 1.64% |
| CYTK | CYTOKINETICS INC | 1.64% |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.61% |
| AMGN | AMGEN CORP | 1.60% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.56% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.52% |
| SNY | SANOFI- AVENTIS- ADR | 1.49% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.46% |
| EW | EDWARDS LIFESCIENCES CORP | 1.43% |
| IMVT | IMMUNOVANT INC | 1.32% |
| BDX | BECTON DICKINSON & CO | 1.30% |
| LNTH | LANTHEUS HOLDINGS INC | 1.30% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.29% |
| MRK | MERCK & CO. NEW | 1.28% |
| DHR | DANAHER CORP | 1.28% |
| REGN | REGENERON PHARMACEUTICALS | 1.20% |
| BIIB | BIOGEN INC | 1.16% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.13% |
| PCVX | VAXCYTE INC | 1.10% |
| ZTS | ZOETIS INC | 1.09% |
| ELV | ELEVANCE HEALTH INC | 1.00% |
| DYN | DYNE THERAPEUTICS, INC. | 1.00% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 0.93% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.89% |
| APLS | APELLIS PHARMACEUTICALS INC | 0.85% |
| DXCM | DEXCOM INC | 0.85% |
| UNH | UNITEDHEALTH GROUP INC | 0.83% |
| XNCR | XENCOR INC. | 0.81% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.75% |
| NVO | NOVO NORDISK A/S | 0.69% |
| AVTR | AVANTOR, INC. | 0.68% |
| VKTX | VIKING THERAPEUTICS, INC. | 0.67% |
| TNDM | TANDEM DIABETES CARE INC | 0.66% |
| ARVN | ARVINAS INC USD | 0.64% |
| KURA | KURA ONCOLOGY INC | 0.57% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.32% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.24% |
| AKROCV | CONTRA AKERO THERAPEUT | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.